Best Practice Exchange in advanced UC - Clinical case 2: Second-line and salvage treatment options after platinum-based chemotherapy
In this episode of our clinical case discussion podcast, experts explore second-line and salvage treatment options for patients with advanced urothelial cancer. Gain up-to-date information on novel tr...
2 Mar 202211min
Best Practice Exchange in advanced UC - Clinical case 1: Cisplatin-ineligible first-line treatment
In this episode of a series of podcasts exploring treatment options for patients with advanced urothelial cancer, our experts discuss the options for a patient who has previously undergone surgery, an...
23 Feb 202214min
Best Practice Exchange in advanced UC - Clinical case 2: Locally Advanced Bladder Cancer
In this episode of our podcast series exploring the best treatment strategies for patients with advanced urothelial cancer, our two experts discuss the most appropriate treatment for a patient with lo...
15 Feb 202211min
Best Practice Exchange in advanced UC - Clinical case 1: Cisplatin-eligible first-line treatment for metastatic disease
In this first of a series of advanced urothelial cancer clinical case discussions, two experts discuss the first-line treatment strategy for a newly-diagnosed patient who is eligible for cisplatin-bas...
8 Feb 202212min
Renal Cell Carcinoma – Second and subsequent lines of therapy
Clinicians face challenging decisions on what treatment strategies to use after progression on combination therapy. Also, adverse event management is an important aspect of patient care. Dr. Manuela S...
25 Jan 20224min
Renal Cell Carcinoma – First-Line treatment of metastatic disease
Combinations of ICIs or ICIs with TKIs are now part of the first-line treatment strategy, based on the results of phase III trials. The burning question in clinical practice is whether one ICI-based c...
18 Jan 20228min
Renal Cell Carcinoma – Adjuvant therapy
The benefit of adjuvant therapy in preventing or delaying recurrence and improving survival for patients with localized or locally advanced RCC remains debatable. Dr. Manuela Schmidinger and Dr. Berna...
11 Jan 202212min
Advanced Urothelial Cancer – Second-Line treatment strategies
With immunotherapy shifting to the frontline setting, clinicians face challenging decisions on how to treat patients after progression. Novel treatments are being developed with promising data. Dr. To...
28 Des 20215min
